Cargando…
The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
BACKGROUND: The irinotecan (CPT-11) causes intestinal mucositis and diarrhea that may be related to changes in the enteric nervous system (ENS). In inflammatory condition, mast cells release a variety of pro-inflammatory mediators that can interact with the ENS cells. It has not been explored whethe...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384042/ https://www.ncbi.nlm.nih.gov/pubmed/28388962 http://dx.doi.org/10.1186/s12974-017-0854-1 |
_version_ | 1782520391702413312 |
---|---|
author | Nogueira, Ludmila T. Costa, Deiziane V. S. Gomes, Antoniella S. Martins, Conceição S. Silva, Angeline M. H. P. Coelho-Aguiar, Juliana M. Castelucci, Patrícia Lima-Júnior, Roberto C. P. Leitão, Renata F. C. Moura-Neto, Vivaldo Brito, Gerly A. C. |
author_facet | Nogueira, Ludmila T. Costa, Deiziane V. S. Gomes, Antoniella S. Martins, Conceição S. Silva, Angeline M. H. P. Coelho-Aguiar, Juliana M. Castelucci, Patrícia Lima-Júnior, Roberto C. P. Leitão, Renata F. C. Moura-Neto, Vivaldo Brito, Gerly A. C. |
author_sort | Nogueira, Ludmila T. |
collection | PubMed |
description | BACKGROUND: The irinotecan (CPT-11) causes intestinal mucositis and diarrhea that may be related to changes in the enteric nervous system (ENS). In inflammatory condition, mast cells release a variety of pro-inflammatory mediators that can interact with the ENS cells. It has not been explored whether CPT-11 is able to alter the enteric glial and neuronal cell, and the role of mast cells in this effect. Therefore, this study was conducted to investigate the effect of CPT-11 on the enteric glial and neuronal cells, as well as to study the role of mast cells in the CPT-11-induced intestinal mucositis. METHODS: Intestinal mucositis was induced in Swiss mice by the injection of CPT-11 (60 mg/kg, i.p.) once a day for 4 days following by euthanasia on the fifth day. To investigate the role of mast cells, the mice were pretreated with compound 48/80 for 4 days (first day, 0.6 mg/kg; second day, 1.0 mg/kg; third day, 1.2 mg/kg; fourth day, 2.4 mg/kg) to induce mast cell degranulation before the CPT-11 treatment. RESULTS: Here, we show that CPT-11 increased glial fibrillary acidic protein (GFAP) and S100β gene and S100β protein expressions and decreased HuC/D protein expression in the small intestine segments. Concomitantly, CPT-11 enhanced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels and inducible nitric oxide synthase (iNOS) gene expression, associated with an increase in the total number macrophages (positive cells for ionized calcium-binding adapter molecule, Iba-1) and degranulated mast cells in the small intestine segments and caused significant weight loss. The pretreatment with compound 48/80, an inductor of mast cells degranulation, significantly prevented these CPT-11-induced effects. CONCLUSIONS: Our data suggests the participation of mast cells on the CPT-11-induced intestinal mucositis, macrophages activation, enteric reactive gliosis, and neuron loss. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0854-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5384042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53840422017-04-12 The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis Nogueira, Ludmila T. Costa, Deiziane V. S. Gomes, Antoniella S. Martins, Conceição S. Silva, Angeline M. H. P. Coelho-Aguiar, Juliana M. Castelucci, Patrícia Lima-Júnior, Roberto C. P. Leitão, Renata F. C. Moura-Neto, Vivaldo Brito, Gerly A. C. J Neuroinflammation Research BACKGROUND: The irinotecan (CPT-11) causes intestinal mucositis and diarrhea that may be related to changes in the enteric nervous system (ENS). In inflammatory condition, mast cells release a variety of pro-inflammatory mediators that can interact with the ENS cells. It has not been explored whether CPT-11 is able to alter the enteric glial and neuronal cell, and the role of mast cells in this effect. Therefore, this study was conducted to investigate the effect of CPT-11 on the enteric glial and neuronal cells, as well as to study the role of mast cells in the CPT-11-induced intestinal mucositis. METHODS: Intestinal mucositis was induced in Swiss mice by the injection of CPT-11 (60 mg/kg, i.p.) once a day for 4 days following by euthanasia on the fifth day. To investigate the role of mast cells, the mice were pretreated with compound 48/80 for 4 days (first day, 0.6 mg/kg; second day, 1.0 mg/kg; third day, 1.2 mg/kg; fourth day, 2.4 mg/kg) to induce mast cell degranulation before the CPT-11 treatment. RESULTS: Here, we show that CPT-11 increased glial fibrillary acidic protein (GFAP) and S100β gene and S100β protein expressions and decreased HuC/D protein expression in the small intestine segments. Concomitantly, CPT-11 enhanced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels and inducible nitric oxide synthase (iNOS) gene expression, associated with an increase in the total number macrophages (positive cells for ionized calcium-binding adapter molecule, Iba-1) and degranulated mast cells in the small intestine segments and caused significant weight loss. The pretreatment with compound 48/80, an inductor of mast cells degranulation, significantly prevented these CPT-11-induced effects. CONCLUSIONS: Our data suggests the participation of mast cells on the CPT-11-induced intestinal mucositis, macrophages activation, enteric reactive gliosis, and neuron loss. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0854-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-07 /pmc/articles/PMC5384042/ /pubmed/28388962 http://dx.doi.org/10.1186/s12974-017-0854-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Nogueira, Ludmila T. Costa, Deiziane V. S. Gomes, Antoniella S. Martins, Conceição S. Silva, Angeline M. H. P. Coelho-Aguiar, Juliana M. Castelucci, Patrícia Lima-Júnior, Roberto C. P. Leitão, Renata F. C. Moura-Neto, Vivaldo Brito, Gerly A. C. The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis |
title | The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis |
title_full | The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis |
title_fullStr | The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis |
title_full_unstemmed | The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis |
title_short | The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis |
title_sort | involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384042/ https://www.ncbi.nlm.nih.gov/pubmed/28388962 http://dx.doi.org/10.1186/s12974-017-0854-1 |
work_keys_str_mv | AT nogueiraludmilat theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT costadeizianevs theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT gomesantoniellas theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT martinsconceicaos theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT silvaangelinemhp theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT coelhoaguiarjulianam theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT casteluccipatricia theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT limajuniorrobertocp theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT leitaorenatafc theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT mouranetovivaldo theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT britogerlyac theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT nogueiraludmilat involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT costadeizianevs involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT gomesantoniellas involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT martinsconceicaos involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT silvaangelinemhp involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT coelhoaguiarjulianam involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT casteluccipatricia involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT limajuniorrobertocp involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT leitaorenatafc involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT mouranetovivaldo involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis AT britogerlyac involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis |